USP33 Regulates DNA Damage Response and Carcinogenesis Through Deubiquitylating and Stabilising p53
Cell Proliferation · 2025-05 · 58 (5)
DOI: 10.1111/cpr.13793 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 18.12.2024. Verfasst von Yuqi Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: China National Center for Bioinformation, Beijing, China. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, DNA Damage, Ubiquitin Thiolesterase, Carcinogenesis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, the Innovative Research Group Program of National Science Foundation of China, Youth Innovation Promotion Association Foundation of Chinese Academy of Sciences of China.
Abstract (Originalsprache)
The de‐ubiquitinase USP33 has been shown to possess either tumour‐promoting or inhibitory effect on human cancer cells. However, all these findings are mainly based on in vitro cell culture models, and the in vivo evidence, which is more plausible to digest the functional role of USP33 in carcinogenic process, is still lacking. Here, we demonstrate that USP33 modulates DNA damage responses including cell cycle arrest and apoptosis induction through associating with p53. It directly interacts with p53 to mediate its de‐ubiquitination and further stabilisation under DNA damage condition. Depletion of USP33 induces an enhanced level of p53 ubiquitination, which de‐stabilises p53 protein leading to impaired DNA damage responses. Furthermore, USP33 silencing shows either promoted or inhibited effect on cell proliferation in human cancer cells with p53 WT and mutant background, respectively. Consistently, mice with hepatocyte‐specific USP33 knockout are more sensitive to nitrosodiethylamine (DEN)‐induced hepatocarcinogenesis compared to wild type mice. Thus, our in vitro and in vivo evidences illustrate that USP33 possesses anti‐tumour activity via regulating p53 stability and activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- China National Center for Bioinformation, Beijing, China.
- Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
- University of Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: YongLiang Zhao
Förderung
- National Key R&D Program of China
- the Innovative Research Group Program of National Science Foundation of China
- Youth Innovation Promotion Association Foundation of Chinese Academy of Sciences of China
- the Strategic Priority Research Program of the Chinese Academy of Sciences
- National Key Research and Development Program of China
Zitieren
APA
Zhu, Y., Chen, Z., Niu, K., Li, M., Deng, Y., Zhang, J., Wei, D., Wang, J., & Zhao, Y. (2025). USP33 Regulates DNA Damage Response and Carcinogenesis Through Deubiquitylating and Stabilising p53. Cell Proliferation, 58(5). https://doi.org/10.1111/cpr.13793
Vancouver
Zhu Y, Chen Z, Niu K, Li M, Deng Y, Zhang J, et al. USP33 Regulates DNA Damage Response and Carcinogenesis Through Deubiquitylating and Stabilising p53. Cell Proliferation. 2025;58(5). doi:10.1111/cpr.13793
BibTeX
@article{Zhu2025,
author = {Zhu, Yuqi and Chen, Zixiang and Niu, Kaifeng and Li, Mengge and Deng, Yuchun and Zhang, Ji and Wei, Di and Wang, Jiaqi and Zhao, YongLiang},
title = {USP33 Regulates DNA Damage Response and Carcinogenesis Through Deubiquitylating and Stabilising p53},
journal = {Cell Proliferation},
year = {2025},
volume = {58},
number = {5},
doi = {10.1111/cpr.13793}
}
EUVIMED